We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug & Device Products
FDAnews Books Library
Events
Form 483s Database
Publications
Webinar Training Pass
eCFR and Guidances
Books
Clinical Products
Advertising
White Papers
Contact Us
About Us
COVID-19
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Laureen M. Geniusz
Laureen M. Geniusz
Products
PRODUCTS
Invacare Corp.
Benjamin J. Dastoli
and
Laureen M. Geniusz
Price:
$117.00
View
Cleveland Diagnostics, Inc.
Laureen M. Geniusz
Price:
$117.00
View
Synapse Biomedical, Inc.
Benjamin J. Dastoli
and
Laureen M. Geniusz
Price:
$117.00
View
Invacare Corp.
Laureen M. Geniusz
and
Teresa K. Kastner
Price:
$117.00
View
Steris Corp.
Laureen M. Geniusz
and
Ja'vonica F. Penn
Price:
$117.00
View
Philips Medical Systems, Inc.
Benjamin J. Dastoli
and
Laureen M. Geniusz
Price:
$117.00
View
Valtronic Technologies, Inc.
Benjamin J. Dastoli
and
Laureen M. Geniusz
Price:
$117.00
View
Kapp Surgical Instrument, Inc.
Laureen M. Geniusz
Price:
$117.00
View
Frantz Medical Development Ltd.
Laureen M. Geniusz
Price:
$117.00
View
SPR Therapeutics, Inc.
Laureen M. Geniusz
Price:
$117.00
View
View All Products by Laureen M. Geniusz
Upcoming Events
13
Jul
FDA Ad and Promo Enforcement Trends: Past, Present and Future
27
Jul
Applying the Lessons of the Pandemic to Your Upcoming Trial
28
Jul
EU-MDR’s Growing Pains: Are You Current with the Latest Developments?
28
Jul
Is Your Product a Drug or Device — and Does It Matter?: A Recent Appeals Court Decision Says It Does
02
Aug
Medical Device Cybersecurity: Understand the Latest Developments
03
Aug
Pharmaceutical Process Validation: Best Practices for Success
Featured Products
FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485
Selecting and Implementing Electronic Document Management Systems in the EU
Featured Stories
FDA Warns Baby Neck Floats Used in Water Therapy Can Cause Death or Injury
U.S. Government Inks $3.2 Billion Contract With Pfizer-BioNTech for Vaccine Booster Campaign
FX Receives FDA Clearance for Its FX V135 Shoulder Arthroplasty Platform
FDA Recommends Modified COVID-19 Vaccine Boosters Adapted to Omicron BA.4 and BA.5 Subvariants
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
